Company or ticker...

NeoGenomics

NeoGenomics provides cancer-focused genetic testing and oncology diagnostic services.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

NEO

1.8B

2.5

n/a

19.28%

Key Facts

M. Cap

PS

PE

YTD

1.8B

2.5

n/a

19.28%

10MA

20MA

50MA

200MA

$NEO